Quoin Pharmaceuticals, Ltd.
QNRX
$6.97
-$0.18-2.52%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -7.47% | -14.93% | -10.14% | -6.83% | 3.05% |
| Total Depreciation and Amortization | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 43.56% | 61.98% | 11.82% | -25.53% | -15.58% |
| Change in Net Operating Assets | 848.13% | 74.92% | -160.65% | 675.62% | -129.22% |
| Cash from Operations | 35.42% | 3.30% | -126.24% | 39.63% | -42.10% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -2.45% | 136.55% | -544.00% | 50.82% | -39.25% |
| Cash from Investing | -2.45% | 136.55% | -544.00% | 50.82% | -39.25% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Issuance of Common Stock | -- | -98.88% | -- | -- | -100.00% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -371.25% | -99.69% | 12,294.13% | 0.00% | -752.17% |
| Foreign Exchange rate Adjustments | -180.00% | 183.33% | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 203.96% | -134.90% | 1,123.65% | 107.54% | -1,183.30% |